Core Group

The Core Group (CG) provides leadership and sets the strategic direction for the programs of the WGND. It facilitates and accelerates decision-making and acts as a catalyst for effective implementation of programs and initiatives developed by the membership.

Task Forces

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The CG is composed of the WGND Co-Chairs, the Leaders of the WGND Subgroups and a WGND Community Representative. The WGND Secretariat works with the CG to implement the strategic direction and initiatives of the WGND, develop action items and manage and administer WGND programs and the membership.

Zaid Tanvir

Global Alliance for TB Drug Development
New York, NY

Cherise Scott, PhD, MPH

Global Alliance for TB Drug Development
New York, NY, USA

Wim Vandevelde

Community Representative
Global TB Community Advisory Board
Capetown, South Africa

Albert Makone

Community Representative
Harare, Zimbabwe

Christian Lienhardt, MD, PhD

Critical Trial Capacity Subgroup Leader
Stop TB Partnership Secretariat World Health Organization
Geneva, Switzerland

Tawanda Gumbo

Critical Knowledge & Tools Subgroup Leader
UT Southwestern Medical Center
Dallas, TX, USA

Jacques Grosset, MD

Critical Knowledge & Tools Subgroup Leader
Center for TB Research Johns Hopkins Medicine
Baltimore, MD, USA

Matt Price

Candidates Subgroup Leader
Harvard School of Public Health
Bethesda, MD, USA

Petros C. Karakousis, MD

Biology Targets Subgroup Leader
Center for TB Research, Johns Hopkins University
Baltimore, MD, USA

Thomas Dick

Biology Targets Subgroup Leader
Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore

Mel Spigelman, MD

Global Alliance for TB Drug Development
New York, NY, USA

Barbara Laughon, PhD

Co-Chair & Candidates Subgroup Leader
Bethesda, MD, USA

New Members

The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.

Apply Now

Questions? Contact Us